Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Tag Archives: biotechnology news
Should Preambles “Count” – The Debate Continues
On September 13th, the Fed. Cir. reversed a summary determination of non-infringement which turned on the question of whether or not to give weight to a term that appeared only in the preamble of a claim to a prostate treatment … Continue reading
USPTO Proposes Incentivizing Humanitarian Technologies and Licensing
On Monday, the PTO requested comments on the use of the IP system to incentivize humanitarian technologies and licensing to benefit “impoverished population[s].” A grab-bag of concepts and ideas was set forth, with perhaps the most concrete (and marginally useful) … Continue reading
U.S. Court of Appeals Stays Decision to Bar Stem Cell Funding
A three judge panel of the Court of Appeals for the District of Columbia stayed the recent district court ruling which voided President Obama’s executive order permitting Federal funding for research on an expanded number of embryogenic stem cell lines … Continue reading
Stem Cell Funding Ban Stayed by D.C. Cir.
The United States Court of Appeals for the District of Columbia Circuit stayed the order of the D.C. District Court that had nullified President Obama’s executive order restoring Federal funding for research on embryonic stem cells (ESCs) as conflicting with … Continue reading
Posted in Stem Cells/Cloning
Tagged biotechnology law, biotechnology news, Federal Circuit, stem cells, Warren Woessner
Leave a comment